Carrier-free Nanotherapeutics unleashed: Ce6/siPD-L1 co-delivery system synergizes photodynamic and RNAi therapies to combat breast cancer
- 4 June 2025
- journal article
- Published by Elsevier in International Journal of Biological Macromolecules
- Vol. 318, 144962
Abstract
No abstract availableKeywords
Funding Information
- Priority Academic Program Development of Jiangsu Higher Education Institutions
This publication has 44 references indexed in Scilit:
- Recent Advances in RNA‐Targeted Cancer TherapyChemBioChem, 2023
- Physiological Barriers and Strategies of Lipid‐Based Nanoparticles for Nucleic Acid Drug DeliveryAdvanced Materials, 2023
- Lipid Nanoparticle (LNP) Enables mRNA Delivery for Cancer TherapyAdvanced Materials, 2023
- Electrostatic Attractive Self‐Delivery of siRNA and Light‐Induced Self‐Escape for Synergistic Gene TherapyAdvanced Materials, 2023
- (Nano)platforms in breast cancer therapy: Drug/gene delivery, advanced nanocarriers and immunotherapyMedicinal Research Reviews, 2023
- Drug Self‐Delivery Systems: Molecule Design, Construction Strategy, and Biological ApplicationAdvanced Healthcare Materials, 2023
- Liposomes: Ideal drug delivery systems in breast cancerBiotechnology and Applied Biochemistry, 2021
- The role of mitochondria in cellular toxicity as a potential drug targetCell Biology and Toxicology, 2018
- RNA interference-based therapy and its delivery systemsCancer and Metastasis Reviews, 2017
- Mesoporous Silica Nanoparticles: Synthesis, Biocompatibility and Drug DeliveryAdvanced Materials, 2012